Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary ...

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...

Moderna suffers setback in vaccine patent battle with Pfizer Former medical chief at Seres lands job; Flagship spinout raises $65M Former medical chief at Seres lands job; Flagship spinout raises $65M ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

GlaxoSmithKline (NYSE:GSK) and Pfizer (NYSE:PFE) have agreed to dismiss a U.S. patent lawsuit over Pfizers RSV vaccine, ...

Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and ...

Recent health developments spotlight China's push in brain chip trials, Corcept's successful ovarian cancer drug study, Lilly ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The cost per single dose varies but is typically between £75 and £99.

In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA). These two vaccine ...